Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Pre-participation screening of young competitive athletes for prevention of sudden cardiac death 3. The Job Market for 2008-2009: Compensation 4. Renal Artery Stenosis 5. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease
Your Article Summary
Dystroglycan Matrix Receptor Function in Cardiac Myocytes Is Important for Limiting Activity-Induced Myocardial Damage
Circulation Research, 10/02/09
Michele DE et al. – The findings suggest dystroglycan function as an extracellular matrix receptor in cardiac myocytes plays a primary role in limiting myocardial damage from spreading to neighboring cardiac myocytes, and loss of dystroglycan matrix receptor function in cardiac muscle cells is likely important in the development of cardiomyopathy in glycosylation–deficient muscular dystrophies.
Related Articles
Detection of Myocardial Damage in Patients With Sarcoidosis
Circulation, 11/05/09
Relevance Score: 66%
Continuous Coronary Sinus Perfusion Reverses Ongoing Myocardial Damage in Acute Ischemia
Artificial Organs, 11/04/09
Relevance Score: 66%
Myocardial fibrosis and apoptosis, but not inflammation, are present in long-term experimental diabetes
Heart And Circulatory Physiology, 10/16/09
Relevance Score: 66%
Comparison of Prolonged Bivalirudin Infusion Versus Intraprocedural in Preventing Myocardial Damage After Percutaneous Coronary Intervention in Patients With Angina Pectoris
The American Journal of Cardiology, 10/14/09
Relevance Score: 66%
Asymptomatic Low Ankle-Brachial Index in Vascular Surgery Patients: A Predictor of Perioperative Myocardial Damage
European Journal of Vascular and Endovascular Surgery, 10/12/09
Relevance Score: 66%
Today in Myocardium/Pericardium...keeping you current
Receive free subspecialty "5-minute updates" via email
Doxorubicin Cardiomyopathy
Cardiology, 12/11/09
Mechanisms of Myocardium - Coronary Vessel Interaction
Heart And Circulatory Physiology, 12/11/09
Evidence of clinical practice heterogeneity in the use of implantable cardioverter-defibrillators in heart failure and post–myocardial infarction left ventricular dysfunction: Findings from IMPROVE HF
Heart Rhythm, 12/11/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


